Details of the Drug Reposition

General Information of This Drug (ID: DMUSTAW)

Drug Name
hESC-derived RPE (MA09-hRPE)   DMUSTAW

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myopic macular degeneration DIS7ADVV 9B75.Y Phase 1/2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Stargardt disease DISPXOTO 9B70 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02122159) Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration
2 ClinicalTrials.gov (NCT01625559) Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)